(Q40835931)

24 September 2017

0 references

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate (English)

1 reference

24 September 2017

1 reference

Masaya Ishibashi

1

1 reference

24 September 2017

Taku Fujimura

2

1 reference

24 September 2017

Akira Hashimoto

3

1 reference

24 September 2017

Takahiro Haga

4

1 reference

24 September 2017

Kaoru Onami

5

1 reference

24 September 2017

Akira Tsukada

6

1 reference

24 September 2017

Yumi Kambayashi

7

1 reference

24 September 2017

Takanori Hidaka

8

1 reference

24 September 2017

Sadanori Furudate

9

1 reference

24 September 2017

Ryoko Shimada

10

1 reference

24 September 2017

Setsuya Aiba

11

1 reference

24 September 2017

11 January 2012

1 reference

Case reports in dermatology

24 September 2017

1 reference

24 September 2017

4

1 reference

24 September 2017

1

1 reference

24 September 2017

5-9

1 reference

Myeloid derived suppressor cells and their role in tolerance induction in cancer

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Role of matrix metalloproteinases (MMPs) in colorectal cancer

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Matrix metalloproteinase-1 expression in splenic angiosarcoma metastasizing to the serous membrane

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Docetaxel monotherapy for angiosarcoma in an elderly patient

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3271839

Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies

1 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22308113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Radiation therapy for angiosarcoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22308113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22308113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000335999

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

22308113

1 reference